At least, not until the comic book sequel. In Prometheus: Fire and Stone - Omega by Kelly Sue DeConnick and Agustin Alessio, ...
The deal for Prometheus will give New Jersey-based Merck more exposure to the immunology space. Prometheus is in late stage clinical trials for PRA023, a drug for Crohn's disease and other autoimmune ...